A.I. Virtanen Institute for Molecular Sciences - News

A multilingual website has just been launched to help citizens understand and reduce their daily exposure to endocrine disrupting chemicals (EDCs) present in the environment.

The BEETHOVEN project will generate a robust, multi-dimensional evidence base linking nutrition to mental health across life stages and diverse population groups.

The identified immuno-metabolic biomarkers may, following further validation, serve as potential biomarkers for adolescent depression.

This year’s topics include Future Clinical RDI, Personalised Medicine, Prevention, and Aging.

The thesis explores two approaches for reducing anesthesia while minimizing motion during preclinical fMRI measurements.

Common medications used to treat anemia may also slow down cancer cell growth and prevent new blood vessels from forming.

Smaller plastic particles have more effects on neurons, the key information processing cells of the brain, new research shows. Neuronal cells were exposed to polystyrene nanoplastics at low doses to study subtle changes.

The findings of the doctoral research may help develop new gene therapy and regenerative medicine approaches for ischemic heart disease and heart failure.

The purpose of AtheroPortal is to facilitate researchers’ access to data on atherosclerosis, and thereby accelerate the identification of new disease mechanisms, biomarkers, and potential drug development targets.

Leading international experts present the latest research and envisage the future at the Kuopio Neuroscience 50 Years symposium on 15–17 June 2026.